Institutional investors purchased a net $11.6 million shares of INSM during the quarter ended March 2015 and now own 88.27% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
TEACHER RETIREMENT SYSTEM OF TEX... Bought 795.00 shares of Insmed Inc
STATE STREET GLOBAL ADVISORS LTD... Bought 300.00 shares of Insmed Inc
PRIVAT BANK PATRIMONIO SGIIC SA Sold 2.0 Thousand shares of Insmed Inc